Get 40% Off
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas toolCopy Portfolio

Cimpress' (CMPR) Q2 Earnings Beat Estimates, Revenues Miss

Published 01/30/2020, 07:54 AM
Updated 07/09/2023, 06:31 AM
CTAS
-
CMPR
-
B
-
BERY
-

Cimpress N.V. (NASDAQ:CMPR) reported mixed second-quarter fiscal 2020 results, wherein earnings surpassed the Zacks Consensus Estimate but revenues lagged the same.

The company’s adjusted earnings came in at $2.73 per share, surpassing the Zacks Consensus Estimate of $2.25. Moreover, the bottom grew 25.8% from the year-ago quarter figure of $2.17.

Cimpress N.V Price, Consensus and EPS Surprise

Cimpress N.V price-consensus-eps-surprise-chart | Cimpress N.V Quote

Quarter Details

Total revenues in the fiscal second quarter were $820.3 million compared with $825.6 million a year ago. Also, the top line missed the consensus estimate of $841 million.

National Pen segment generated revenues of about $128 million, down 3.8% year over year. Vistaprint — the largest revenue generating segment of the company — reported aggregate revenues of $433.3 million, down from $443.9 million.

Upload and Print segment’s revenues increased to $214.1 million from $203.8 million in the year-ago quarter. The segment consists of two subgroups — PrintBrothers and The Print Group. PrintBrothers’ revenues increased to $126.6 million from $116.3 million, whereas The Print Group generated $87.7 million, roughly flat year over year. Moreover, revenues from All Other Businesses increased to $49.8 million from $48.3 million.

Margin Details

In the quarter, Cimpress' cost of revenues was $394 million, down 4.3% on a year-over-year basis. It represented 48% of total revenues. Total selling, general & administrative expenses declined 10.2% to $225.2 million. It represented 27.5% of revenues in the fiscal second quarter.

Gross profit increased 2.9% year over year to $426.3 million, with margin expanding 180 basis points to 52%. Net interest expenses fell 6.5% to $15.7 million.

Balance Sheet and Cash Flow

As of Dec 31, 2019, Cimpress had $36.9 million in cash and cash equivalents compared with $48.3 million in the prior-year quarter. Also, the company’s total debt (net of issuance costs), was $1,370.3 million, up from $1,048.4 million.

In the fiscal second quarter, Cimpress repurchased 2,279,736 shares for $305.3 million. Net cash provided by operating activities was $202.2 million, higher than $183.3 million in the year-ago quarter.

Outlook

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

For fiscal 2020, the company estimates National Pen’s sales growth to be in the range of flat-to-low single-digit (at constant currency), while the same for Vistaprint is projected to be in the range of flat-to-negative.

Zacks Rank & Stocks to Consider

Cimpress currently carries a Zacks Rank #3 (Hold).

Some better-ranked stocks are Barnes Group, Inc. (NYSE:B) , Berry Global Group, Inc. (NYSE:BERY) Cintas Corporation (NASDAQ:CTAS) . All these companies carry a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Barnes Group delivered positive earnings surprise of 4.21%, on average, in the trailing four quarters.

Berry Global delivered positive earnings surprise of 0.70%, on average, in the trailing four quarters.

Cintas pulled off positive earnings surprise of 8.50%, on average, in the trailing four quarters.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>



Berry Global Group, Inc. (BERY): Free Stock Analysis Report

Cintas Corporation (CTAS): Free Stock Analysis Report
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .


Barnes Group, Inc. (B): Free Stock Analysis Report

Cimpress N.V (CMPR): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.